ULK1 and hyperinsulinemic hypoglycemia, familial, 4: The first one involves the activation of the Ulk1/Atg1 protein kinase complex that is inhibited by the mechanistic target of rapamycin (mTOR) and activated by AMP-activated protein kinase (AMPK) during nutrient deficiency.